Earlier today, Immune Therapeutics, Inc. (OTCQB: IMUN) announced that Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) has approved the company’s patented Lodonal™ as an over-the-counter, non-toxic adjunct therapy in the treatment of HIV/AIDS. With this approval, IMUN’s distribution partners, AHAR Pharma and GB Pharma Holdings, will now be able to launch […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.